These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31183574)

  • 1. Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplantation: Management Principles.
    Smibert O; Satlin MJ; Nellore A; Peleg AY
    Curr Infect Dis Rep; 2019 Jun; 21(7):26. PubMed ID: 31183574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches.
    Pérez-Nadales E; Fernández-Ruiz M; Gutiérrez-Gutiérrez B; Pascual Á; Rodríguez-Baño J; Martínez-Martínez L; Aguado JM; Torre-Cisneros J
    Transpl Infect Dis; 2022 Aug; 24(4):e13881. PubMed ID: 35691028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy.
    Errico G; Gagliotti C; Monaco M; Masiero L; Gaibani P; Ambretti S; Landini MP; D'Arezzo S; Di Caro A; Parisi SG; Palù G; Vespasiano F; Morsillo F; Moro ML; Procaccio F; Ricci A; Grossi PA; Pantosti A; Nanni Costa A;
    Clin Microbiol Infect; 2019 Feb; 25(2):203-209. PubMed ID: 29800674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.
    Satlin MJ; Jenkins SG; Walsh TJ
    Clin Infect Dis; 2014 May; 58(9):1274-83. PubMed ID: 24463280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae.
    Everett M; Sprynski N; Coelho A; Castandet J; Bayet M; Bougnon J; Lozano C; Davies DT; Leiris S; Zalacain M; Morrissey I; Magnet S; Holden K; Warn P; De Luca F; Docquier JD; Lemonnier M
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients.
    Satlin MJ; Walsh TJ
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28815897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and successful containment of a carbapenem-resistant Enterobacteriaceae outbreak in a Southern Italian Transplant Institute.
    Mularoni A; Martucci G; Douradinha B; Campanella O; Hazen B; Medaglia A; Arena G; Gruttadauria S; Tuzzolino F; Arcadipane A; Gioè S; Luca A; Conaldi PG; Grossi P; Gridelli B
    Transpl Infect Dis; 2019 Aug; 21(4):e13119. PubMed ID: 31112353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pre-transplant carbapenem-resistant Enterobacterales colonization and/or infection on solid organ transplant outcomes.
    Taimur S; Pouch SM; Zubizarreta N; Mazumdar M; Rana M; Patel G; Freire MP; Pellett Madan R; Kwak EJ; Blumberg E; Satlin MJ; Pisney L; Clemente WT; Zervos MJ; La Hoz RM; Huprikar S
    Clin Transplant; 2021 Apr; 35(4):e14239. PubMed ID: 33527453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical impact of infections with carbapenem-resistant enterobacteriaceae in liver transplant recipients].
    Lübbert C; Hau HM; Rodloff A; Mössner J; Mischnik A; Bercker S; Bartels M; Kaisers UX
    Z Gastroenterol; 2015 Nov; 53(11):1276-87. PubMed ID: 26562402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbapenemase-producing organisms in solid organ transplantation.
    Wong D; van Duin D
    Curr Opin Organ Transplant; 2019 Aug; 24(4):490-496. PubMed ID: 31169529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin- and carbapenem-resistant Enterobacteriaceae.
    Freire MP; de Oliveira Garcia D; Cury AP; Francisco GR; Dos Santos NF; Spadão F; Bueno MFC; Camargo CH; de Paula FJ; Rossi F; Nahas WC; David-Neto E; Pierrotti LC
    Eur J Clin Microbiol Infect Dis; 2019 Apr; 38(4):755-765. PubMed ID: 30680569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging trends in epidemiology and management of infections caused by carbapenem-resistant Enterobacteriaceae.
    Martirosov DM; Lodise TP
    Diagn Microbiol Infect Dis; 2016 Jun; 85(2):266-75. PubMed ID: 27033631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging superbugs: The threat of Carbapenem Resistant Enterobacteriaceae.
    Dong LT; Espinoza HV; Espinoza JL
    AIMS Microbiol; 2020; 6(3):176-182. PubMed ID: 33134739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drugs for difficult bugs: management of multidrug-resistant gram-negative infections in solid organ transplant recipients.
    Pouch SM
    Curr Opin Organ Transplant; 2021 Aug; 26(4):424-431. PubMed ID: 34148979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections Caused by Carbapenem-Resistant
    Sheu CC; Chang YT; Lin SY; Chen YH; Hsueh PR
    Front Microbiol; 2019; 10():80. PubMed ID: 30761114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.
    Pfaller MA; Huband MD; Mendes RE; Flamm RK; Castanheira M
    Int J Antimicrob Agents; 2018 Aug; 52(2):144-150. PubMed ID: 29510189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the INCREMENT-SOT-CPE score in a large cohort of liver transplant recipients with carbapenem-resistant Enterobacterales infection.
    Rinaldi M; Bonazzetti C; Gallo M; Ferraro G; Freire M; Terrabuio DRB; Tandoi F; Romagnoli R; De Rosa FG; Mularoni A; Ferrarese A; Burra P; Halpern M; Balbi E; Simkins J; Abbo L; Morrás I; Cantero M; Alagna L; Bandera A; Clemente WT; Valerio M; Fernández A; Muñoz P; Statlender L; Yahav D; Camargo LFA; Girão ES; Grossi P; Viale P; Curti S; Giannella M;
    Transpl Infect Dis; 2023 Apr; 25(2):e14036. PubMed ID: 36880576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship.
    Jean SS; Gould IM; Lee WS; Hsueh PR;
    Drugs; 2019 May; 79(7):705-714. PubMed ID: 30972660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenem-Resistant Enterobacteriaceae.
    Iovleva A; Doi Y
    Clin Lab Med; 2017 Jun; 37(2):303-315. PubMed ID: 28457352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.